Baxter International Inc (BAX)
29.59
+0.01
(+0.03%)
USD |
NYSE |
Jan 08, 16:00
29.99
+0.40
(+1.35%)
Pre-Market: 04:59
Baxter International SG&A Expense (Quarterly): 754.00M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 1.562B |
| Haemonetics Corp | 106.95M |
| Becton Dickinson & Co | 1.256B |
| Globus Medical Inc | 240.74M |
| Accuray Inc | 24.50M |